(Q42163532)

17 October 2017

title

Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics (English)

1 reference

17 October 2017

0 references

5

1 reference

17 October 2017

G Martinotti

1

1 reference

17 October 2017

S Andreoli

2

1 reference

17 October 2017

M Di Nicola

3

1 reference

17 October 2017

M Di Giannantonio

4

1 reference

17 October 2017

L Janiri

6

1 reference

17 October 2017

publication date

1 July 2008

1 reference

17 October 2017

number of pages

8

1 reference

inferred from page(s)

published in

Human Psychopharmacology

1 reference

17 October 2017

volume

23

1 reference

17 October 2017

issue

5

1 reference

17 October 2017

page(s)

417-424

1 reference

Psychotogenic drug use and neuroleptic response

17 October 2017

cites work

1 reference

Impaired sleep in alcohol misusers and dependent alcoholics and the impact upon outcome

21 January 2018

1 reference

The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence

21 January 2018

1 reference

Benzodiazepine treatment for alcohol-dependent patients

21 January 2018

1 reference

Drug Treatment of Anxiety and Depression in Detoxified Alcoholic Patients

21 January 2018

1 reference

Pharmacological treatment of substance-abusing schizophrenic patients

21 January 2018

1 reference

Dopamine and alcohol relapse: D1 and D2 antagonists increase relapse rates in animal studies and in clinical trials

21 January 2018

1 reference

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

21 January 2018

1 reference

7 January 2021

Borderline personality–bipolar spectrum relationship

1 reference

7 January 2021

Bipolar disorder and substance abuse

1 reference

7 January 2021

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

1 reference

7 January 2021

Substance abuse in bipolar disorder

1 reference

7 January 2021

Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry

1 reference

7 January 2021

Quetiapine in relapse prevention in alcoholics suffering from craving and affective symptoms: a case series

1 reference

7 January 2021

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

7 January 2021

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

1 reference

7 January 2021

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism

1 reference

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

7 January 2021

Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties

1 reference

7 January 2021

Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

1 reference

7 January 2021

Olanzapine treatment for patients with schizophrenia and substance abuse

1 reference

7 January 2021

Quetiapine for alcohol use and craving in bipolar disorder

1 reference

7 January 2021

Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders

1 reference

7 January 2021

Patterns of alcohol consumption in bipolar patients comorbid for alcohol abuse or dependence

1 reference

7 January 2021

The Fifth Edition of the Addiction Severity Index

1 reference

7 January 2021

Quetiapine for treatment of alcohol dependence.

1 reference

7 January 2021

Borderline personality disorder and alcoholism treatment: a one-year follow-up study

1 reference

7 January 2021

Quetiapine for the treatment of borderline personality disorder; an open-label study

1 reference

7 January 2021

Effects of Three Interview Factors on the Validity of Alcohol Abusers' Self-Reports

1 reference

7 January 2021

The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities

1 reference

7 January 2021

Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions

1 reference

7 January 2021

Dopamine and alcoholism: neurobiological basis of ethanol abuse

1 reference

7 January 2021

Quetiapine in the treatment of rapid cycling bipolar disorder.

1 reference

7 January 2021

Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission

1 reference

7 January 2021

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.944

1 reference

17 October 2017

1 reference